Bendamustine, Ofatumumab and High-Dose Methylprednisolone (BOMP) in Relapsed/Refractory CLL: Results of a Planned Interim Analysis of the French CLL Intergroup ICLL01 Phase II Trial

Affiliation auteurs!!!! Error affiliation !!!!
TitreBendamustine, Ofatumumab and High-Dose Methylprednisolone (BOMP) in Relapsed/Refractory CLL: Results of a Planned Interim Analysis of the French CLL Intergroup ICLL01 Phase II Trial
Type de publicationJournal Article
Year of Publication2014
Auteursde Guibert S, Dilhuydy M-S, Ysebaert L, Sanhes L, Choquet S, Aurran-Schleinitz T, Guieze R, Mahe B, Daguindau N, Araujo C, Saad H, Ferrant E, Cazin B, Feugier P, Dreyfus B, Alain D, Lepretre S, Le Garff-Tavernier M, Lauren V, Schuh A, Pereira B, Leblond V, Tournilhac O
JournalBLOOD
Volume124
Date PublishedDEC 6
Type of ArticleMeeting Abstract
ISSN0006-4971